Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumour endothelial cell reprogramming orchestrates angiocrine signalling to drive chemoresistance in breast cancer.

Angiogenesis·2026
Same author

Glycosylated extracellular matrix drives immune suppression by modulating macrophage-T cell crosstalk in triple-negative breast cancer.

Nature communications·2026
Same author

Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses.

Molecular cancer therapeutics·2026
Same author

Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responses.

Molecular cancer therapeutics·2026
Same author

Collaborating With Schools for Public Health Research in England: Lessons Learned for Successful Partnerships.

Environmental health insights·2026
Same author

Multi-omics qualification of an organ-on-a-chip model of osteolytic bone metastasis.

Acta biomaterialia·2025

Related Experiment Video

Updated: Apr 10, 2026

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.9K

Interleukin-6 Stimulates Defective Angiogenesis.

Ganga Gopinathan1, Carla Milagre1, Oliver M T Pearce1

  • 1Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom.

Cancer Research
|June 18, 2015
PubMed
Summary

Interleukin 6 (IL6) promotes tumor growth and angiogenesis, but impairs vessel maturation by affecting pericyte coverage. Targeting IL6 may improve cancer therapies by enhancing vessel normalization.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.6K
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

10.2K

Related Experiment Videos

Last Updated: Apr 10, 2026

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.9K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.6K
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

10.2K

Area of Science:

  • Oncology
  • Vascular Biology
  • Immunology

Background:

  • Interleukin 6 (IL6) is implicated in tumor promotion.
  • IL6's role in angiogenesis, particularly vessel maturation, requires further investigation.

Purpose of the Study:

  • To investigate the angiogenic potential of IL6.
  • To elucidate the mechanisms underlying IL6-induced angiogenesis and its impact on vessel maturation.

Main Methods:

  • Ex vivo aortic ring assay to assess vessel sprouting and endothelial cell behavior.
  • In vivo studies using ovarian cancer xenografts treated with anti-IL6 antibody.
  • Analysis of human ovarian cancer biopsies for correlations between IL6, Jagged1, and Angiopoietin 2 (Ang2).

Main Results:

  • IL6 directly induced vessel sprouting, endothelial cell proliferation, and migration, comparable to VEGF.
  • IL6-stimulated vessels exhibited defective pericyte coverage.
  • IL6 mediated effects on pericytes via Jagged1 and Angiopoietin 2 (Ang2) pathways.
  • Anti-IL6 treatment restored pericyte coverage in ovarian cancer xenografts.
  • Positive correlation between IL6, Jagged1, and Ang2 levels in human ovarian cancer biopsies.

Conclusions:

  • IL6 is a potent angiogenic factor that also impairs vessel maturation.
  • Targeting IL6 may represent a therapeutic strategy to normalize tumor vasculature.
  • Findings provide insights into angiogenesis in cancer and inflammatory diseases.